Invivyd, Inc. (IVVD)
1.21
+0.05
(+4.31%)
USD |
NASDAQ |
May 15, 16:00
1.20
-0.01
(-0.83%)
Pre-Market: 09:18
Invivyd Profit Margin (Quarterly) : -301.2% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| MannKind Corp. | -18.43% |
| Altimmune, Inc. | -- |
| Cellectar Biosciences, Inc. | -- |
| Karyopharm Therapeutics, Inc. | -63.86% |
| REGENXBIO, Inc. | -1.41K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.14% |
| Return on Assets | -45.61% |
| Return on Invested Capital | -59.49% |
| Gross Profit Margin (Quarterly) | 88.76% |
| Operating Margin (Quarterly) | -313.9% |
| Return on Net Operating Assets | -296.8% |